Wancheng Guo

Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Editorial: Unraveling renal cell carcinoma: pathogenesis, therapeutic strategies, and future perspectives.

Editorial: Unraveling renal cell carcinoma: pathogenesis, therapeutic strategies, and future perspectives.

Journal: Frontiers in medicine

Published: July 23, 2026

Stress Hyperglycemia Ratio as a Predictor of All-Cause and Cardiovascular Mortality in the General Population: Insights From NHANES 2001-2018.

Stress Hyperglycemia Ratio as a Predictor of All-Cause and Cardiovascular Mortality in the General Population: Insights From NHANES 2001-2018.

Journal: International journal of endocrinology

Published: July 18, 2025

Nanoparticles-enhanced CAR-T cell therapy: current advances and future directions.

Nanoparticles-enhanced CAR-T cell therapy: current advances and future directions.

Journal: Biomarker research

Published: July 16, 2025

Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages.

Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages.

Journal: Blood cancer journal

Published: July 11, 2024

A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation.

A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation.

Journal: Cancers

Published: February 04, 2024

Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.

Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.

Journal: Blood cancer journal

Published: December 16, 2023

Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.

Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.

Journal: Nature communications

Published: July 11, 2023

Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS.

Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS.

Journal: Blood advances

Published: June 30, 2023

High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma.

High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma.

Journal: Cell reports. Medicine

Published: April 17, 2023

Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma.

Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma.

Journal: Heliyon

Published: March 13, 2023

Immune infiltration and drug specificity analysis of different subtypes based on functional status in angioimmunoblastic T-cell lymphoma.

Immune infiltration and drug specificity analysis of different subtypes based on functional status in angioimmunoblastic T-cell lymphoma.

Journal: Heliyon

Published: February 28, 2023

HIF-PH Encoded by EGLN1 Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia.

HIF-PH Encoded by EGLN1 Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 12, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026